Problem Substance
Rosiglitazone (trade name Avandia)
17 research abstracts
AI Summary
Key Findings
Research Overview
- Total Abstracts
- 17
- Action Type
- Problem Substance
- Natural Substances
- 1
- Diseases
- 26
- Research Documents
- 1
- Articles
- 1
Rosiglitazone (trade name Avandia) is an action with 17 research abstracts on GreenMedInfo. Explore the evidence-based research below covering 27 related substances and health topics.
Articles about Rosiglitazone (trade name Avandia)
View all 1 articles
Oct 06, 2013
Please Stay Away from These Drugs for Type 2 Diabetes
Introduction The research is quite clear – oral medications to treat type 2 diabetes do not alter the long-term progression of the disease. While these drugs can be quite effective in the short term,...
doctormurray
5 min
Loading...
No found.
Loading ...
Downloadable Document - Rosiglitazone (trade name Avandia)
16 articles
CK 108
Premium
Related Topics
Diabetes Mellitus: Type 2
(7)
Heart Failure
(5)
Osteoporosis
(5)
Myocardial Infarction
(5)
Cardiotoxic
(5)
Cardiac Mortality
(3)
Cardiovascular Diseases
(2)
Aging
(2)
Chemically-Induced Liver Damage
(2)
Diabetes: Cardiovascular Illness
(2)
Health Topic
Action
